Basit öğe kaydını göster

dc.contributor.authorAyer, Mesut
dc.contributor.authorOzturk, Sukru
dc.contributor.authorYildirim, Naciye
dc.contributor.authorGuvenc, Serkan
dc.contributor.authorPalanduz, Sukru
dc.contributor.authorDincol, Guncag
dc.contributor.authorTutkan, Gulcin
dc.date.accessioned2021-03-03T18:29:16Z
dc.date.available2021-03-03T18:29:16Z
dc.date.issued2006
dc.identifier.citationDincol G., Ozturk S., Palanduz S., Tutkan G., Yildirim N., Ayer M., Guvenc S., "A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3 ; 14)(p21.1 ; q24.1)", AMERICAN JOURNAL OF HEMATOLOGY, cilt.81, sa.11, ss.883-887, 2006
dc.identifier.issn0361-8609
dc.identifier.otherav_4f572d59-3926-418a-a263-bf8023776825
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/56581
dc.identifier.urihttps://doi.org/10.1002/ajh.20684
dc.description.abstractMyelodysplastic syndrome (MDS) with erythroid hypoplasia, a rare form of MDS, has not yet been clearly defined. We report here a 20-year-old woman with severe transfusion-dependent anemia and reticulocytopenia. White blood cells and platelet counts were normal. Bone marrow examination showed a low percentage of erythroid precursors (6%) and a marked dyserythropoiesis and dysmegakaryopoiesis. A diagnosis of MDS (refractory anemia according to the FAB classification) with erythroid hypoplasia was made. Cytogenetic analysis of the bone marrow and peripheral blood revealed a 46,XX,t(3;14)(p21.1;q24.1) translocation, which was confirmed by fluorescence in situ hybridization analysis. This translocation was detected in the apparently healthy younger brother, father, and aunt (father's sister) of the patient. Clonality of T cells in the patient was not confirmed by the polymerase chain reaction and heteroduplex temperature-gradient gel electrophoresis. IgM serology for B19 parvovirus was negative. Other conditions known to be associated with erythroid hypoplasia, such as thymoma, were not present. The patient failed to respond to immunosuppressive therapy (antithymocyte globulin and cyclosporin A). Administration of recombinant human erythropoietin improved her anemia. To our knowledge, this balanced translocation, namely t(3;14)(p21.1;q24.1), which is present both in the patient with MDS with erythroid hypoplasia and in the healthy members of the family, has not been defined previously.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleA case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3 ; 14)(p21.1 ; q24.1)
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF HEMATOLOGY
dc.contributor.department, ,
dc.identifier.volume81
dc.identifier.issue11
dc.identifier.startpage883
dc.identifier.endpage887
dc.contributor.firstauthorID13013


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster